title: [Impact of dyslipidemia on the onset and progression of diabetic complications].
authors.forename: Shinji
authors.initials: S
authors.lastname: Kitajima
authors.forename: Kengo
authors.initials: K
authors.lastname: Furuichi
authors.forename: Takashi
authors.initials: T
authors.lastname: Wada
mesh_terms: D002561:Cerebrovascular Disorders / Q000209:etiology / Q000517:prevention & control; D003327:Coronary Disease / Q000209:etiology* / Q000517:prevention & control; D003925:Diabetic Angiopathies / Q000209:etiology* / Q000517:prevention & control*; D003928:Diabetic Nephropathies / Q000209:etiology* / Q000517:prevention & control*; D050171:Dyslipidemias / Q000150:complications* / Q000378:metabolism; D011345:Fenofibrate / Q000008:administration & dosage; D005919:Glomerular Filtration Rate; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage; D000960:Hypolipidemic Agents / Q000008:administration & dosage; D007328:Insulin / Q000502:physiology; D012307:Risk Factors
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D007328:Insulin; D011345:Fenofibrate